Search bioRxiv⌕ Search

Biology subjects

Viswanathan, B.

Publications and source records attributed to Viswanathan, B..

2 recordsLinked to original sources

Evolutionary convergence of a Pyroptosis-Apoptosis crosstalk drives non-canonical inflammasome signalling.

The coordination of efficient immune responses to infections is essential to enable pathogen clearance and host survival. Cell death modalities are a crucial component of the innate immune system and are key to controlling intracellular and extracellular infections. Human caspase-4 and -5 are cysteine proteases activated upon intracellular detection of bacterial lipopolysaccharide (LPS) and triggers pyroptosis, a lytic and pro-inflammatory form of cell death. However, the interaction between these caspases and other cell death modalities remains poorly understood. Here, we build on evidence that caspase-4 can engage in crosstalk with the apoptotic executioner caspases-3 and -7. Our work validated caspase-3 and -7 as direct substrates of caspase-4 and -5, and demonstrated that this specificity was regulated by exosite interactions as opposed to the tetrapeptide. Using AlphaFold, we generated an interaction model between caspase-4 and executioner caspases-3 and -7. From this, we experimentally validated the importance of a hydrophobic interface on caspase-3 and -7 that engaged the caspase-4 exosite, enabling their recognition and cleavage. Importantly, this interface is not used by the apoptotic initiator caspase-8, which cleaved caspase-3 in a tetrapeptide-dependent manner. Our work highlights that inflammatory caspases have evolved a novel mechanism to coordinate crosstalk between pyroptotic and apoptotic signalling, and suggests that these pathways may synergise for the efficient amplification of cell death pathways.

biochemistry↗

The effect of circulating neutralizing antibodies on the replication of SARS-CoV-2 variants following post-vaccination infections.

The impact of pre-existing neutralizing antibodies (NAbs) titers on SARS-CoV-2 viral shedding dynamics in post-vaccination infection (PVI) are not well understood. We characterized viral shedding longitudinally in nasal specimens in relation to baseline (pre/peri-infection) serum neutralizing antibody titers in 125 participants infected with distinct SARS-CoV-2 variants. Among 68 participants who had received vaccinations, we quantified the effect of baseline serum NAb titers on maximum viral RNA titers and on the duration of infectivity. Baseline NAb titers were higher and efficiently targeted a broader range of variants in participants who received one or two monovalent ancestral booster vaccinations compared to those with a full primary vaccine series. In participants with Delta variant infections, baseline NAb titers targeting Delta were negatively correlated with maximum viral RNA copies. Per log10 increase in baseline NAb IC50, maximum viral load was reduced -2.43 (95% confidence interval [CI] -3.76, -1.11) log10 N copies and days of infectious viral shedding were reduced -2.79 [95% CI: -4.99, -0.60] days. By contrast, in those with Omicron infections (BA.1, BA.2, BA.4 or BA.5 lineages) baseline NAb responses against Omicron lineages did not predict viral outcomes. Our results provide robust estimates of the effect of baseline NAbs on the magnitude and duration of nasal viral replication after PVI (albeit with an unclear effect on transmission) and show how immune escape variants efficiently evade these modulating effects.

immunology↗